Error-free genome duplication and segregation are ensured through the timely activation of ubiquitylation enzymes. The anaphase-promoting complex or cyclosome (APC/C), a multisubunit E3 ubiquitin ligase, is regulated by phosphorylation. However, the mechanism remains elusive. Using systematic reconstitution and analysis of vertebrate APC/Cs under physiological conditions, we show how cyclin-dependent kinase 1 (CDK1) activates the APC/C through coordinated phosphorylation between Apc3 and Apc1. Phosphorylation of the loop domains by CDK1 in complex with p9/Cks2 (a CDK regulatory subunit) controlled loading of coactivator Cdc20 onto APC/C. A phosphomimetic mutation introduced into Apc1 allowed Cdc20 to increase APC/C activity in interphase. These results define a previously unrecognized subunit-subunit communication over a distance and the functional consequences of CDK phosphorylation. Cdc20 is a potential therapeutic target, and our findings may facilitate the development of specific inhibitors.
M
any biological processes are regulated by posttranslational modifications, such as phosphorylation and ubiquitylation. The anaphase-promoting complex or cyclosome (APC/C) (1-3) is an unusually large multisubunit (>13) enzyme and a key component of the cellular machinery that regulates cell cycle progression and genome stability by catalyzing ubiquitylation of regulatory proteins, such as securin and cyclin B, which leads to their proteolysis (4) (5) (6) . The activity of the APC/C controls mitotic exit. Antimicrotubule agents that disrupt spindle function are effective in the clinic, because they cause mitotic delay, which triggers apoptosis of cancer cells. However, microtubules have key roles in neuronal functions, so the development of agents that block cells in mitosis without altering microtubules is important. One way to do this would be to target the APC/C (7) (8) (9) (10) (11) . Mitotic kinases, including cyclin-dependent kinase 1 (CDK1), phosphorylate vertebrate APC/C at more than 50 sites during mitosis (12, 13) , and the coactivator subunit Cdc20 preferentially binds to and activates phosphorylated APC/C (14) (15) (16) . However, all the evidence in vertebrates that CDK1 activates the APC/C comes from in vitro phosphorylation and ubiquitylation studies, and no mutagenesis of these sites has been done. To elucidate how CDK phosphorylates and activates the APC/C, we reconstituted recombinant Xenopus APC/C by simultaneous coexpression of all the subunits using an advanced baculovirus-insect cell expression system (17, 18) (fig. S1 , A and B). The activities of purified APC/C were assessed under physiological conditions in a cyclin B-destruction assay reconstituted in Xenopus egg extracts. Incubation of reconstituted recombinant APC/C in extract from which endogenous APC/C was depleted (DAPC/C+APC/C) revealed that the reconstituted APC/C was active and degraded a substrate, cyclin B (fig. S1, C and D). The purified APC/C also ubiquitylated and degraded substrates in a manner dependent on the Cdc20 homolog 1 (Cdh1) (fig. S1, E and F). Cdh1, an alternative coactivator of the APC/C in the G 1 phase, activates the APC/C independently of subunit phosphorylation. These results indicated that our reconstituted Xenopus APC/C was functional. We mutated all conserved (between Xenopus and humans) CDK consensus phosphorylation sites of each individual subunit to alanine (A) and made mutant APC/Cs, one subunit at a time (table S1). The cyclin-destruction assay in anaphase revealed that only APC/C Apc1-15A (the reconstituted APC/C containing 15 mutated CDK sites on Apc1) and APC/C Apc3-12A mutants showed decreased activity (Fig. 1A and fig. S2A ). The integrity of the APC/C was confirmed in a Cdh1-dependent assay. The activities of APC/ C Apc3-12A and APC/C Apc1-15A were similar to that of wild type (WT), although APC/C Apc1-15A showed reduced activity ( fig. S2 , B and C). These results prompted us to further investigate Apc3 and Apc1.
In the absence of a coactivator, the APC/C is always inactive. We examined the binding of Cdc20 to APC/C Apc3-12A and APC/C Apc1-15A
. We confirmed that APC/C WT bound Cdc20 in a cell cycle-dependent manner; binding was low in interphase and high in anaphase (Fig. 1B) . Consistent with the destruction assay in anaphase, APC/C Apc3-12A showed a lower affinity for Cdc20 than APC/C WT (Fig. 1B) . Cdc20 also failed to bind APC/C Apc1-15A in anaphase (Fig. 1C) . No shift in the electrophoretic band containing Apc3 or Apc1 was detected in anaphase extract for APC/C or APC/C Apc1-15A
, respectively (Fig. 1, B and C) , consistent with the mutated CDK sites no longer being phosphorylated. This was confirmed by in vitro phosphorylation using purified CDK1-cyclin B (Fig. 1D) .
Why is the phosphorylation of two subunits, Apc3 and Apc1, of particular importance? Cdc20 directly binds the Apc3 subunit through the C-terminal IR (Ile-Arg) motif of Cdc20 (19 , and APC/C Apc3-9A mutants also showed reduced Cdc20 binding in anaphase extract (Fig. 2B, lanes 16 to 20) . Although the predicted loop domain consists of~280 residues, all of which are conserved among vertebrates ( fig. S4 ), their function remains uncharacterized. Complexes of the Xenopus p9 protein (Suc1 or Cks1/2 in other organisms) (20) with CDK1 only bound to WT APC/C when phosphorylated in anaphase but not in interphase ( Fig. 2B and fig.  S5A ). The Apc3 loop mutants failed to bind p9-CDK1 (Fig. 2B , lanes 17 to 19), consistent with findings that p9 is required for phosphorylation of Apc3 in anaphase (15, 21, 22) . The Suc1/Cks family of proteins may recognize CDK sites and stimulate phosphorylation-dependent CDK signaling (23, 24) . Thus, CDK phosphorylation of the loop domain in Apc3 might recruit p9-CDK1 and lead to phosphorylation of Apc1, another key CDK target in the APC/C. Furthermore, we examined the physical interaction between Apc3 fragments and p9. A bacterially purified fragment from the loop domain (residues 202 to 342) bound to p9 in mitotic egg extracts, whereas the same fragment with CDK site mutations did not bind p9 ( fig. S5B ). These results indicate that Apc3 functions as a scaffold for p9-CDK1 through the loop domain.
To investigate the mechanism of Apc1 phosphorylation-dependent APC/C activation, we sought to identify key phosphorylation sites on Apc1 (Fig. 2C) . We made a series of mutant Apc1-APC/Cs (fig. S6A ). The construct with CDK mutations in a predicted flexible loop domain (Apc1-7A) reduced cyclin destruction in anaphase, whereas all the others showed similar, more rapid cyclin B destruction kinetics ( fig. S6, B and C, and fig. S7 ). In a Cdh1-supplemented destruction assay, all the constructs showed activity similar to that of APC/ C WT (fig. S6, D and E). Cdc20 loading was also assessed. Cdc20 loading to the APC/C in anaphase was abolished by the 7A mutation (Fig. 2D, lane  25) , whereas in interphase extract, APC/C Apc1-7A retained basal Cdc20 binding as seen with APC/ C WT (Fig. 2D, lanes 15 and 18) . These results indicate that phosphorylation of the loop domain mutated in APC/C Apc1-7A is necessary for Cdc20 binding and subsequent APC/C activation. To verify the relation between Apc1 and Apc3 phosphorylation, we raised a phosphospecific antibody that bound to the Apc1 loop domain only when S314 and S318 were phosphorylated ( fig.  S8 ). The specificity of this antibody was verified with bacterially produced peptide containing Apc1 residues 294 to 399 (hereafter Apc1 loop ) incubated either in anaphase or interphase extract ( fig. S8 , A and C). The CDK sites on Apc1 loop were barely phosphorylated in Apc3 CDK-site mutant APC/ Cs, whereas they were highly phosphorylated in APC/C WT in anaphase (Fig. 2E) . retain some APC/C-dependent cyclin-destruction activity, we tested the phenotype of the double mutant. APC/C Apc3-9A/Apc1-7A appeared more deficient in cyclin destruction than APC/C Apc1-7A or APC/C Apc3-9A alone (Fig. 3A and fig. S9 ). APC/ C Apc3-9A/Apc1-7A failed to destroy cyclin A as well as securin (Fig. 3B) . We also investigated the activity of APC/C Apc3-9A/Apc1-7A using a "cycling" frog egg extract where the endogenous APC/C is replaced by APC/C Apc3-9A/Apc1-7A ( fig. S10 ). Unlike WT, APC/ C Apc3-9A/Apc1-7A could not support cyclin or securin destruction. Consistently, an in vitro phosphorylated APC/C Apc3-9A/Apc1-7A showed less activity than APC/C WT in an in vitro ubiquitylation assay ( Fig.  3C and fig. S11 ). Thus, phosphorylation of Apc1 and Apc3 subunits is crucial for APC/C activation. However, it is conceivable that phosphorylation of other subunits or an alternative pathway (e.g., by means of phosphatases) might be involved to some extent in vivo (Fig. 3A and fig. S12 ). Nevertheless, if phosphorylation of Apc3 and Apc1 is important, an Apc1 phosphomimetic mutation [Asp (D)] might bypass both Apc3 and Apc1 phosphorylation and make CDK phosphorylation dispensable. We tested this in interphase extracts, in which neither CDK nor APC/C-Cdc20 is active. If Apc1 had the phosphomimetic mutation (7D), the APC/C was activated by Cdc20 even in interphase, which triggered cyclin B destruction, albeit with slower kinetics than those observed with APC/C in anaphase (Fig. 3D and fig. S13A ). The Apc1-7D gain-of-function phenotype was further confirmed by a "cycling" extract and an in vitro ubiquitylation assay (fig. S13, B and C) . These results indicate that the phosphorylation status of SCIENCE sciencemag.org 27 phosphorylates the APC/C and stimulates Cdc20 loading and subsequent ubiquitylation catalysis ("active"). Conversely, at the end of mitosis, the APC/C is dephosphorylated by an as-yet-unidentified phosphatase, which contributes to the inactivation of APC/C-Cdc20. (Bottom) CDK1-dependent phosphorylation-relay for activation of the APC/C. p9-CDK1-cyclinB initially phosphorylates the internal loop domain of Apc3, which allows p9 (Cks2) bound CDK1-cyclin B loading to Apc3. p9-CDK1-cyclin B then stimulates phosphorylation of the internal loop domain of Apc1. The loop domain seems to block Cdc20-NTD access to the APC/C (e.g., Apc8) when it is not phosphorylated, but upon phosphorylation, the loop loses its inhibitory function, which allows Cdc20 NTD loading and subsequent ubiquitylation catalysis.
cyclin B. APC/Cs recovered using anti-Apc3 affinity beads were subjected to cyclin B ubiquitylation assay in the presence or absence of Cdc20. . APC/C complexes were incubated with Cdc20 NTD (N159-5A) in interphase or anaphase extract depleted of endogenous APC/C and Cdc20 (DAPC/C DCdc20). APC/C was recovered with anti-Apc3 beads, and bound proteins were analyzed by immunoblotting.
the Apc1 loop is a crucial determinant of Cdc20 loading and activation of the APC/C.
We found that, in coimmunoprecipitation assays, Apc1 loop-7A (the Apc1 loop carrying 7A mutation) bound to the APC/C in anaphase extract, whereas the WT Apc1 loop fragment did not (Fig.  3E) . Conversely, these phosphomimetic mutations abolished the interaction with the APC/C ( fig. S14) , which highlighted how the interaction of the Apc1 loop with the APC/C depends on its phosphorylation status. In the atomic structure of human APC/C Cdh1.Emi1 determined using cryoelectron microscopy (25) , residues corresponding to the Apc1 loop are disordered and not observed in the electron microscopy density map. However, given the putative location of Apc1 loop proximal to the regulatory N-terminal domain of Cdh1 (Cdh1 NTD ) (25) (fig. S15 ), phosphorylation-dependent structural changes of Apc1 loop could influence the APC/C binding sites for the NTD of coactivator located on Apc8 (25, 26) , the PC domain of Apc1 (25) , and Apc6 (26) . Consistent with this idea, Cdc20-NTD binding was reduced in APC/C Apc1-7A compared with APC/C WT (Fig. 3F ). Our results reveal the presence and importance of the coordinated phosphorylation of Apc3 and Apc1 within the APC/C complex for the control of the APC/C in mitosis (Fig. 4) . Extended flexible loops in both subunits have a key role; one acts as a scaffold of p9-CDK1 and the other for phosphorylation-dependent interaction with Cdc20-NTD. Previous studies in yeast and Drosophila provide in vivo evidence that CDK1 phosphorylation of the APC/C is required for its mitotic activity (22, 27, 28) . Our present study extends past findings of (13) (14) (15) (16) 22) and uncovers the mechanistic insight and the functional consequences of APC/C phosphorylation in vertebrates. Cdc20 [not Cdh1, which is a tumor suppressor (29) ] is a promising anticancer therapeutic target (7, 8, 10, 30) . The Apc1 loop may provide a target for strategies to specifically inhibit APC/C-Cdc20. The position and orientation of the mitotic spindle is precisely regulated to ensure the accurate partition of the cytoplasm between daughter cells and the correct localization of the daughters within growing tissue. Using magnetic tweezers to perturb the position of the spindle in intact cells, we discovered a force-generating machinery that maintains the spindle at the cell center during metaphase and anaphase in one-and two-cell Caenorhabditis elegans embryos. The forces increase with the number of microtubules and are larger in smaller cells. The machinery is rigid enough to suppress thermal fluctuations to ensure precise localization of the mitotic spindle, yet compliant enough to allow molecular force generators to fine-tune the position of the mitotic spindle to facilitate asymmetric division.
T he position and orientation of the mitotic spindle determines the plane of cell division, which, in turn, determines how the cytoplasmic contents are partitioned to the daughter cells (1) and how the daughter cells are localized within the tissue (2) . After the spindle reaches the cell center before metaphase, its position and orientation must be precisely maintained (3) until the cell enters anaphase. The molecular forces underlying the maintenance of spindle position and orientation are not known.
Although much is known about how force is generated by purified proteins (4) and in cell extracts (5), little is understood about how molecular forces are integrated in vivo to serve complex cellular processes, such as spindle positioning. This is due to the difficulties of exerting and measuring forces in intact cells. Indeed, with the exception of the landmark paper by Nicklas in 1983 (6) that measured forces associated with spindle elongation during anaphase, there has been no direct quantitative measurement of forces on mitotic spindles in cells [see (7, 8) ].
To measure mitotic forces in vivo, we injected 1.0-mm-diameter superparamagnetic beads (9) and used magnetic tweezers (10) to exert calibrated forces of up to 200 pN to mitotic spindles in one-and two-cell Caenorhabditis elegans embryos, a model system for studying mitosis (1) (Fig. 1A and figs. S1 to S4) (see supplementary methods). We applied forces of 20 to 60 pN to the centrosome at one of the spindle's poles for up to 20 s during metaphase, when the spindle is in a relatively quiescent phase at the cell center (Fig. 1A) . In response to force, the spindle rotated as the centrosome was displaced up to 3 mm from the anterior-posterior (A-P) axis (Fig. 1, B and C, and movie S1). Thus, it was possible to perturb the position and orientation of the spindle by using magnetic forces.
The kinetics of spindle displacement indicated that the mitotic spindle is held at the cell center by viscoelastic forces. First, after the onset of the force, the centrosome moved with an approximately constant velocity during the first few seconds ( Fig.  2A, average displacement) , which suggested that the spindle is subject to viscous forces. Second, the displacement speed decreased after several
